3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Tuberous Sclerosis
5
Seizures
4
Marijuana Abuse
3
Colonic Neoplasms
3
Breast Neoplasms
3
Sturge-Weber Syndrome
2
Nausea
2
Lennox Gastaut Syndrome
2
Glioblastoma
2
Epilepsies, Myoclonic
2
Anxiety Disorders
2
Vomiting
1
Tuberous Sclerosis 2
1
Tuberous Sclerosis 1
1
Spasms, Infantile
1
Solid Tumor
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Parasomnias
1
Pancreatic Neoplasms
1
Pain
1
Neoplasms
1
Multiple Myeloma
1
Liver Neoplasms
1
Liver Cirrhosis
1
Gallbladder Neoplasms
1
Epilepsy
1
Dysgeusia
1
Drug Resistant Epilepsy
1
Colorectal Neoplasms
1
Interventions
Fentanyl
23
Analgesia
22
Morphine
19
Acupuncture Therapy
18
Zoledronic Acid
15
Oxycodone
14
Acetaminophen
14
Ketamine
13
Radiotherapy
12
Therapeutics
11
Methadone
11
Lidocaine
11
nabiximols
10
Ibandronic Acid
10
Hydromorphone
10
Bupivacaine
10
Surveys and Questionnaires
8
Ropivacaine
8
Psychiatric Rehabilitation
7
Early Intervention, Educational
7
Saline Solution
6
Music Therapy
6
Cryotherapy
6
Cryosurgery
6
Yoga
5
Water
5
Tapentadol
5
Pregabalin
5
Methods
5
Massage
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Pain
×
Cannabidiol
×
Clear all
NCT03948074
2025-09-10
CAFCARS
British Columbia Cancer Agency
Phase 2
Completed
91 enrolled